Cite
HARVARD Citation
Vogel, A. et al. (2016). Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT). BMC cancer. 16 (1), pp. 1-10. [Online].